Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P U Feig

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
JAMA|November 1, 1976
Vasculitis with urticaria, hypocomplementemia, and multiple system involvementP U Feig, N A Soter, H M Yager, et al.
Clinical and Experimental Dialysis and Apheresis|January 1, 1982
Hemodialysis in the treatment of life-threatening hyperphosphatemiaP U Feig, P Hirszel, M A Galen, et al.
Clinical Therapeutics|November 1, 1993
The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild-to-moderate hypertension. Adalat CC Cooperative Study GroupP U Feig, L Gibson, E P Mac Carthy, et al.
Clinical Therapeutics|November 1, 1993
The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients. Adalat CC Cooperative Study GroupE P Mac Carthy, P P Pettis, L Gibson, et al.
Journal of Clinical Pharmacology|May 1, 1993
A comparison of once-daily atenolol and metoprolol using office and ambulatory blood pressure monitoringG H Rutan, P U Feig, S May, et al.
Diabetes Care|May 1, 1997
The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet aloneP Segal, P U Feig, G Schernthaner, et al.
Diabetes Care|April 16, 1998
Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibitionP S Johnston, P U Feig, R F Coniff, et al.
Diabetes Care|April 16, 1998
Long-term titrated-dose alpha-glucosidase inhibition in non-insulin-requiring Hispanic NIDDM patientsP S Johnston, P U Feig, R F Coniff, et al.
Clinical Pharmacology and Therapeutics|November 1, 1986
Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanationK R Sweeney, D J Chapron, J L Brandt, et al.
The Online Journal of Current Clinical Trials|November 24, 1993
The ABCD (Appropriate Blood Pressure Control in Diabetes) trial. Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetesS Savage, N Johnson Nagel, R O Estacio, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
JAMA|November 1, 1976
Vasculitis with urticaria, hypocomplementemia, and multiple system involvementP U Feig, N A Soter, H M Yager, et al.
Clinical and Experimental Dialysis and Apheresis|January 1, 1982
Hemodialysis in the treatment of life-threatening hyperphosphatemiaP U Feig, P Hirszel, M A Galen, et al.
Clinical Therapeutics|November 1, 1993
The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild-to-moderate hypertension. Adalat CC Cooperative Study GroupP U Feig, L Gibson, E P Mac Carthy, et al.
Clinical Therapeutics|November 1, 1993
The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients. Adalat CC Cooperative Study GroupE P Mac Carthy, P P Pettis, L Gibson, et al.
Journal of Clinical Pharmacology|May 1, 1993
A comparison of once-daily atenolol and metoprolol using office and ambulatory blood pressure monitoringG H Rutan, P U Feig, S May, et al.
Diabetes Care|May 1, 1997
The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet aloneP Segal, P U Feig, G Schernthaner, et al.
Diabetes Care|April 16, 1998
Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibitionP S Johnston, P U Feig, R F Coniff, et al.
Diabetes Care|April 16, 1998
Long-term titrated-dose alpha-glucosidase inhibition in non-insulin-requiring Hispanic NIDDM patientsP S Johnston, P U Feig, R F Coniff, et al.
Clinical Pharmacology and Therapeutics|November 1, 1986
Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanationK R Sweeney, D J Chapron, J L Brandt, et al.
The Online Journal of Current Clinical Trials|November 24, 1993
The ABCD (Appropriate Blood Pressure Control in Diabetes) trial. Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetesS Savage, N Johnson Nagel, R O Estacio, et al.
Pageof 4